A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer

Abroad (travel likely)Recruiting

Conditions

Thyroid Cancer · Thyroid · Refractory Thyroid Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Laura Boucai, PhD) · 646-608-3906

Study leads

Laura Boucai, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up

Thyroid Cancer · Intermediate Risk

Abroad (travel likely)RecruitingPHASE3

Pointe à Pitre, France · Angers, France

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

Breast Cancer · Prostate Cancer · Colorectal Cancer

Abroad (travel likely)Recruiting

New York, United States · Mexico City, Mexico

Environmental Factors and Thyroid Cancer

Thyroid Cancer

Abroad (travel likely)Recruiting

New York, United States

The Association Between Bilateral Intermediate Cervical Plexus Block During Total Thyroidectomy and Surgical Stress Response

Thyroid Cancer · Thyroid and Parathyroid Surgery · Hyperthyreosis and Goiter

Abroad (travel likely)RecruitingPHASE4

Zagreb, Croatia